PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16204963-4	2005	Intraperitoneally and orally administered 20(S)-ginsenoside Rh2 to t-BHP-injured mice significantly inhibited the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities.	tert-Butylhydroperoxide	67-72	glutamic pyruvic transaminase, soluble	Mus musculus	132-156	
28025122-4	2017	Pretreatment with rutaecarpine prior to the injection of t-BHP significantly prevented the increase in serum levels of AST, ALT, and lipid peroxidation in mice liver.	tert-Butylhydroperoxide	57-62	glutamic pyruvic transaminase, soluble	Mus musculus	124-127	
25691908-4	2015	t-BHP injection caused dramatic elevation of serum AST, ALT, and LDH level, while TCW pretreatment notably attenuated these elevations.	tert-Butylhydroperoxide	0-5	glutamic pyruvic transaminase, soluble	Mus musculus	56-59	
18824057-2	2008	Pretreatment with AC prior to the administration of t-BHP significantly prevented the increase in serum levels of hepatic enzyme markers (ALT, AST) and lipid peroxidation and reduced oxidative stress, as measured by glutathione content, in the liver.	tert-Butylhydroperoxide	52-57	glutamic pyruvic transaminase, soluble	Mus musculus	138-141	
16162168-9	2005	Nevertheless, both ginsenoside Rb1 and compound K significantly inhibited the increment of ALT and AST induced by t-BHP in mice, when it was orally administered.	tert-Butylhydroperoxide	114-119	glutamic pyruvic transaminase, soluble	Mus musculus	91-94	
16204963-4	2005	Intraperitoneally and orally administered 20(S)-ginsenoside Rh2 to t-BHP-injured mice significantly inhibited the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities.	tert-Butylhydroperoxide	67-72	glutamic pyruvic transaminase, soluble	Mus musculus	158-161